Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis. [electronic resource]
- International journal of antimicrobial agents Aug 2014
- 131-5 p. digital
Publication Type: Journal Article
1872-7913
10.1016/j.ijantimicag.2014.03.017 doi
Adult Aged Aged, 80 and over Anti-Bacterial Agents--adverse effects Clarithromycin--pharmacology Cohort Studies Drug Resistance, Bacterial Erythromycin--adverse effects Female Humans Lung Diseases--drug therapy Male Middle Aged Mycobacterium avium Complex--drug effects Mycobacterium avium-intracellulare Infection--drug therapy Propensity Score Retrospective Studies Treatment Outcome